The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Cited by (1,000)

Items 701–800 of 1,000

1. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease
   Junli Xue, Min Zhao, Yunchao Liu, Xiubin Jia, Xiaoyi Zhang, Qianqian Gu, Yunbo Xie, Shucun Qin, Boyan Liu · 2023 · European Journal of Pharmacology
2. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
   Xiaolei Miao, Ping Luo, Jiao Liu, Junjun Wang, Yong Chen · 2023 · Lipids in Health and Disease
3. From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients
   Furong Huang, Bo Lyu, Fanci Xie, Fang Li, Yufeng Xing, Zhiyi Han, Jianping Lai, Jinmin Ma, Yuanqiang Zou, Hua Zeng et al. · 2024 · Frontiers in Microbiology
4. Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis
   Gaurav Kistangari, Rocío López, Bo Shen · 2017 · Inflammatory Bowel Diseases
5. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis
   Waleska Cláudia Dornas, Vincent Lagente · 2019 · Pharmacological Research
6. Physiopathologie des stéatoses hépatiques métaboliques
   Rodolphe Anty, Philippe Gual · 2019 · La Presse Médicale
7. Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
   P. Nahon, M. Allaire, J. Nault, V. Paradis · 2020 · Hepatic Oncology
8. Cigarette smoking status alters dysbiotic gut microbes in hypertensive patients
   Pan Wang, Ying Dong, Jie Jiao, Kun Zuo, Chunming Han, Lei Zhao, Shu Ding, Xinchun Yang, Mulei Chen, Jing Li · 2021 · Journal of Clinical Hypertension
9. Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
   Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Saleh Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M. Sanai, Alexandre Soares Rosado, Consolato Maria Sergi · 2024 · Biomedicines
10. Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Tharani Senavirathna, Armaghan Shafaei, Ricky R. Lareu, Lois A. Balmer · 2024 · Antioxidants
11. Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
    Małgorzata Moszak, Monika Szulińska, Marta K. Walczak-Galezewska, Paweł Bogdański · 2021 · International Journal of Environmental Research and Public Health
12. RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis
    Linghua Yu, Linlin Wang, Xiaojun Wu, Huixing Yi · 2021 · Communications Biology
13. Flammulinavelutipes Polysaccharides Modulate Gut Microbiota and Alleviate Carbon Tetrachloride-Induced Hepatic Oxidative Injury in Mice
    Yingyin Xu, Zhiyuan Zhang, Bo Wang, Xiaolan He, Jie Tang, Weihong Peng, Jie Zhou, Yong Wang · 2022 · Frontiers in Microbiology
14. Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model
    Ditte Olsen Lützhøft, Tim Sinioja, Berit Østergaard Christoffersen, Rasmus Riemer Jakobsen, Dawei Geng, Hajar Fauzan Ahmad, Ellen Marie Straarup, Karen‐Margrethe Pedersen, Witold Kot, Henrik Duelund Pedersen et al. · 2022 · BMC Microbiology
15. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status
    Josip Stojić, Michał Kukla, Ivica Grgurević · 2023 · Diagnostics
16. Microbiota, Liver Diseases, and Alcohol
    Anne‐Marie Cassard, Philippe Gérard, Gabriel Perlemuter · 2017 · Microbiology Spectrum
17. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
    Tien Sy Dong, Jonathan P. Jacobs · 2019 · Experimental Biology and Medicine
18. Homeostasis of gut microbiota protects against polychlorinated biphenyl 126-induced metabolic dysfunction in liver of mice.
    H. Su, Jiang-zheng Liu, Guangyuan Wu, Zi Long, Junshu Fan, Zhongrui Xu, Jia-Wei Liu, Zhong-Tian Yu, Meng Cao, N. Liao et al. · 2020 · Science of the Total Environment
19. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
    Phillipp Hartmann, Bernd Schnabl · 2021 · Seminars in Liver Disease
20. Sodium butyrate ameliorates non‐alcoholic fatty liver disease by upregulating miR‐150 to suppress CXCR4 expression
    Ning Zhang, Yunfei Qu, Bo Qin · 2021 · Clinical and Experimental Pharmacology and Physiology
21. In Vivo Tissue Distribution of Microplastics and Systemic Metabolomic Alterations After Gastrointestinal Exposure
    Marcus A. Garcia, Aaron S. Romero, Seth D. Merkley, Jewel L. Meyer-Hagen, Charles Forbes, Eliane El Hayek, David P. Sciezka, Rachel Templeton, Jorge González-Estrella, Yan Jin et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
22. The impact of novel probiotics isolated from the human gut on the gut microbiota and health
    Robert Caesar · 2024 · Diabetes Obesity and Metabolism
23. Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases
    Sathish Kumar Perumal, Madan Kumar Arumugam, Natalia A. Osna, Karuna Rasineni, Kusum K. Kharbanda · 2025 · Frontiers in Nutrition
24. Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
    Sniedze Laivacuma, Olga Oblate, Aleksejs Derovs · 2025 · Microorganisms
25. Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Federica Perazza, Laura Leoni, Beatrice Selvatici, Francesca Girolami, Alessia Bonalumi, Alice Beretta, S. Ferri, Maria Letizia Petroni, Fabio Piscaglia, Federico Ravaioli et al. · 2025 · Nutrients
26. Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease
    Benjamin Frederick Theis, Jun Sung Park, Jin Seok Kim, Sareh Zeydabadinejad, Matam Vijay–Kumar, Beng San Yeoh, Piu Saha · 2025 · Biomedicines
27. Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy
    Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, Chieh-Ju Lee, Hsien-Chen Mon, Chen‐Ta Chi, I‐Cheng Lee, Yu-Lun Kuo, Shih-Hsuan Chou, Jiing–Chyuan Luo et al. · 2025 · Hepatology
28. Implication of the Gut Microbiota in Metabolic Inflammation Associated with Nutritional Disorders and Obesity
    Julie Rodriguez, Marta Olivares, Nathalie M. Delzenne · 2020 · Molecular Nutrition & Food Research
29. Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
    Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy · 2022 · Frontiers in Nutrition
30. Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice
    Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang · 2022 · Foods
31. Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment
    Yanbo Wang, Zengbo Wang, Yang Wan, Furong Jin, Xiaodan Shi, Zhishuang Xing, Bo Tian, Bailiang Li · 2023 · Frontiers in Nutrition
32. The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective
    Tingting Qin, Xiuying Chen, Jiahui Meng, Qianqian Guo, Shan Xu, Shanshan Hou, Ziqiao Yuan, Wenzhou Zhang · 2023 · Critical Reviews in Food Science and Nutrition
33. Role of FXR in the development of NAFLD and intervention strategies of small molecules.
    Jiachan Long, Yuanhang Xu, Xuerong Zhang, Bingxin Wu, Cai-Yan Wang · 2024 · Archives of Biochemistry and Biophysics
34. How to Diagnose Nonalcoholic Fatty Liver Disease
    Nimantha Mark Wilfred de Alwis, Quentin Mark Anstee, Christopher Paul Day · 2016 · Digestive Diseases
35. Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
    Cláudia Balhesteiro Marchese Strey, Luiz Alberto De Carli, Sérgio Ricardo Pioner, Marciane Fantinelli, Sabrina S. Gobbato, Guilherme Fagundes Bassols, Alexandre Losekann, Gabriela Perdomo Coral · 2018 · Annals of Hepatology
36. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome
    Stephen D. H. Malnick, Yaakov Maor · 2020 · Visceral Medicine
37. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment
    Feryal Savari, Seyed Ali Mard · 2024 · Heliyon
38. Changes of bacterial communities and bile acid metabolism reveal the potential “intestine-hepatopancreas axis” in shrimp
    Shicheng Bao, Wenjun Wang, Zhixuan Deng, Renjun Zhou, Shenzheng Zeng, Dongwei Hou, Jianguo He, Zhijian Huang · 2024 · The Science of The Total Environment
39. Gut microbiome and liver diseases
    Jun Xu, Ning Chen, Li Zhou, Yulan Liu · 2024 · Fundamental Research
40. The Role of Gut Microbiota in Host Lipid Metabolism: An Eye on Causation and Connection
    Kai Wang, Xianyi Liang, Yanli Pang, Changtao Jiang · 2019 · Small Methods
41. Sodium Acetate Inhibit TGF-β1-Induced Activation of Hepatic Stellate Cells by Restoring AMPK or c-Jun Signaling
    Weiwei Li, Mingjuan Deng, Jiahui Gong, Xiaoying Zhang, Shaoyang Ge, Liang Zhao · 2021 · Frontiers in Nutrition
42. Nuciferine prevents hepatic steatosis associated with improving intestinal mucosal integrity, mucus-related microbiota and inhibiting TLR4/MyD88/NF-κB pathway in high-fat induced rats
    Jiemin Fan, Jingyue Sun, Tingting Li, Xiaoxue Yan, Yihong Jiang · 2021 · Journal of Functional Foods
43. Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms
    Shujun Ye, Yang Liu, Te Zhang, Huijin Feng, Yanqing Liu, Lianjun Ma · 2022 · Frontiers in Pharmacology
44. Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease
    Satu Pekkala · 2023 · International Journal of Molecular Sciences
45. The role of small intestinal bacterial overgrowth in obesity and its related diseases
    Qinyan Yao, Zihan Yu, Qingguo Meng, Jihua Chen, Yaxin Liu, Wenxuan Song, Xiangfeng Ren, Jinjie Zhou, Xin Chen · 2023 · Biochemical Pharmacology
46. Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications
    Gong-Jing Guo, Fei Yao, Wei-Peng Lu, Haoming Xu · 2023 · World Journal of Hepatology
47. Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD
    Daniela Gabbia, Sara De Martin · 2023 · Biology
48. Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis
    Jiayin Chang, Congying Huang, Siqi Li, Xiaolei Jiang, Hong Chang, Minhui Li · 2023 · Molecules
49. Arctium lappa L. polysaccharides alleviate oxidative stress and inflammation in the liver and kidney of aging mice by regulating intestinal homeostasis
    Xueyan Jia, Haoming Liu, Guoliang Yin, Wen Xiang, Haotian Zhao, Xuan Kai Zhang, Xue Ming TANG, Xiang‐Rong Cheng, Chia-Feng Kuo, Chang Liu et al. · 2024 · International Journal of Biological Macromolecules
50. Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters
    Katherine J. P. Schwenger, Julia K. Copeland, Yasaman Ghorbani, Lina Chen, Elena M. Comelli, David S. Guttman, Sandra Elisabeth Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard · 2025 · Microbiome
51. Gut microbiota and non-alcoholic fatty liver disease
    Ludovico Abenavoli, Anna Caterina Procopio, Emidio Scarpellini, Natale POLIMENI, Isabella AQUILA, Tiziana LARUSSA, Luigi BOCCUTO, Francesco Luzza · 2021 · Minerva Gastroenterology
52. Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
    Tianjiao Wang, Xue-Kun Guo, Huji Xu · 2021 · Frontiers in Microbiology
53. Role of gut-microbiota in disease severity and clinical outcomes
    Monika Yadav, Nar Singh Chauhan · 2022 · Briefings in Functional Genomics
54. Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease
    Enhua Mei, Chao Hua Yao, Yi-Nan Chen, Shun-Xue Nan, Sheng-Cai Qi · 2024 · World Journal of Hepatology
55. Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management
    Luigi Elio Adinolfi, Aldo Marrone, Luca Rinaldi, Riccardo Nevola, Antonio Izzi, Ferdinando Carlo Sasso · 2025 · Exploration of Medicine
56. TREM2 in MASH: integrating lipid metabolism and immune response
    Shuyi Shi, Yangyang Y. Zhou, Haiming Zhang, Junli Zhang · 2025 · Frontiers in Immunology
57. Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
    Luyu Wang, Hongtao Wang, Jian‐Lin Wu, Changyi Ji, Ying Wang, Mengmeng Gu, Miaomiao Li, Hong Wei Yang · 2025 · Frontiers in Cellular and Infection Microbiology
58. Obacunone ameliorates high-fat diet-induced MAFLD by regulating the PPARγ-FABP1/CD36 axis and the gut-liver crosstalk
    Xuewen Wang, Jiaming Hong, Rui Liang, Shuoqiang Bao, Lingru Li, Jing Wang, Juan Feng · 2025 · Phytomedicine
59. Regulatory Role and Biomarker Potential of Gut Microbiota Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease to Hepatocellular Carcinoma
    Zongyuan Che, Wei Xue, Xuchen Zhao, Congzhong Hu, Yanzhang Tian · 2025 · Clinical and Translational Gastroenterology
60. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease
    Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu · 2021 · The Anatomical Record
61. Dioxin-like polychlorinated biphenyl 126 (PCB126) disrupts gut microbiota-host metabolic dysfunction in mice via aryl hydrocarbon receptor activation
    Yaran Zhang, Ruina Cui, Guohui Shi, Yi Min Dai, Jiuhong Dong, Qi Wu, Hongxia Zhang, Jiayin Dai · 2022 · Ecotoxicology and Environmental Safety
62. Liver Steatosis: A Marker of Metabolic Risk in Children
    Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini · 2022 · International Journal of Molecular Sciences
63. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats
    Yufan Dai, Wenyu Zhu, Jiaxuan Zhou, Tao Shen · 2022 · Brazilian Journal of Medical and Biological Research
64. Decreased Paneth cell α-defensins promote fibrosis in a choline-deficient L-amino acid-defined high-fat diet-induced mouse model of nonalcoholic steatohepatitis via disrupting intestinal microbiota
    Shunta Nakamura, Kiminori Nakamura, Yuki Yokoi, Yu Shimizu, Shuya Ohira, Mizu Hagiwara, Zihao Song, L. H. Gan, Tomoyasu Aizawa, Daigo Hashimoto et al. · 2023 · Scientific Reports
65. The human microbiome and gut–liver axis in people living with HIV
    Maria Duarte, Phyllis C. Tien, Ma Somsouk, Jennifer C. Price · 2023 · Current HIV/AIDS Reports
66. Phage therapy in gut microbiome
    Xingyao Chen, Beatriz Garcia Mendes, Bruno Secchi Alves, Yi Duan · 2023 · Progress in molecular biology and translational science
67. Factors shaping the gut microbiome of five species of lizards from different habitats
    Diana S. Vasconcelos, David James Harris, Isabel Damas‐Moreira, Ana Mónica Pereira, Raquel Xavier · 2023 · PeerJ
68. Bifidobacterium bifidum BGN4 fractions ameliorate palmitic acid-induced hepatocyte ferroptosis by inhibiting SREBP1-CYP2E1 pathway
    Guangkui Bu, Gang Chen, Juan Li, Dan Wu, Jiangtao Liao · 2023 · Journal of Investigative Medicine
69. Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children
    Jing Ji, Jiahong Sun, Juan Li, Jintang Xie, Bo Xi, Min Zhao · 2023 · Clinical Nutrition
70. Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Georgiana-Diana Cazac, Bogdan Mircea Mihai, Gabriela Ștefănescu, Georgiana-Emmanuela Gîlcă-Blanariu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Cristina-Mihaela Lăcătușu · 2024 · Nutrients
71. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
    Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi · 2024 · Alzheimer s & Dementia
72. The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
    Seema Sharma, Nishant Tiwari, Sampat Singh Tanwar · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
73. Managing nonalcoholic fatty liver disease in patients living with HIV
    Zaid Tafesh, Elizabeth C. Verna · 2016 · Current Opinion in Infectious Diseases
74. Glycyrrhizic acid improving the liver protective effect by restoring the composition of Lactobacillus
    Tianjie Yuan, Jing Wang, Letian Chen, Jinjun Shan, Liuqing Di · 2018 · Journal of Functional Foods
75. The role of the gut microbiome in graft fibrosis after pediatric liver transplantation
    Tian Qin, Jingyuan Fu, Henkjan J. Verkade · 2020 · Human Genetics
76. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis
    Wei Gao, Yufen Wang, Jian Bi, Xiuli Chen, Na Li, Ying-De Wang, Haiying Tang, Jingwei Mao · 2020 · Biochemical and Biophysical Research Communications
77. Metabolic Phenotypes as Potential Biomarkers for Linking Gut Microbiome With Inflammatory Bowel Diseases
    Stanislav N. Iablokov, Natalia S. Klimenko, Daria A. Efimova, Tatiana Shashkova, Pavel S. Novichkov, Dmitry A. Rodionov, Alexander Tyakht · 2021 · Frontiers in Molecular Biosciences
78. Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids
    Xuyang Dai, Linfeng He, Naihua Hu, Chaocheng Guo, Mengting Zhou, Xingtao Zhao, Cheng Wang, Lihong Gong, Cheng Ma, Xinyan Xue et al. · 2021 · Frontiers in Pharmacology
79. Human Gut Microbiota in Cardiovascular Disease
    Daniel Ronen, Yair Rokach, Suzan Abedat, Abed Qadan, Samar Daana, Offer Amir, Rabea Asleh · 2024 · Comprehensive physiology
80. A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease
    Shaojie Huang, Fei Mu, Fei Li, Wenjun Wang, Hạixia Chen, Lei Lü, Yang Ma, Yi Ding, Jingwen Wang · 2020 · Journal of Diabetes Research
81. Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice
    Sena Bluemel, Yanhan Wang, Suhan Lee, Bernd Schnabl · 2020 · World Journal of Gastroenterology
82. Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma
    Thanika Ketpueak, Parameth Thiennimitr, Nattayaporn Apaijai, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn · 2020 · Clinical and Translational Gastroenterology
83. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis
    Ruijun Li, Zhuye Jie, Qiang Feng, Ruiling Fang, Fei Li, Yuan Gao, Huihua Xia, Huanzi Zhong, Bin Tong, Jiayu Xu et al. · 2021 · Frontiers in Cellular and Infection Microbiology
84. The impact of the gut microbiome on liver transplantation
    Nikki K. Duong, Jasmohan Singh Bajaj · 2021 · Current Opinion in Organ Transplantation
85. Sodium butyrate alleviates fructose-induced non-alcoholic fatty liver disease by remodeling gut microbiota to promote γ -amino butyric acid production
    Qu Chen, Lei Wu, Aijia Zhang, Chen Wu, Liuping Cai, Yingping Xiao, Yingdong Ni · 2023 · Food Science and Human Wellness
86. Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota
    Ahmed Mohamed El-Baz, Amira M. El-Ganiny, Doaa Hellal, Hala Magdy Anwer, Hend A. Abd El-Aziz, Ibrahim E. Tharwat, Mohamed A. El-Adawy, Shehab El-Din M. Helal, Menna Tallah A. Mohamed, Tassnim M. Azb et al. · 2023 · AMB Express
87. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review
    Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah · 2023 · World Journal of Hepatology
88. Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis
    Kuanhong Luo, Yang Chen, Shuzheng Fang, Siqi Wang, Zhixin Wu, Huiqing Li · 2023 · Frontiers in Endocrinology
89. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction
    Annette Brandt, Katja Csarmann, Angélica María Hernández-Arriaga, Anja Baumann, Raphaela Staltner, Emina Halilbasic, Michael A Trauner, Amélia Camarinha‐Silva, Ina Bergheim · 2023 · The Journal of Nutritional Biochemistry
90. Natural compounds proposed for the management of non-alcoholic fatty liver disease
    Théodora Merenda, Florian Juszczak, Elisabeth Ferier, Pierre Duez, Stéphanie Patris, Anne‐Émilie Declèves, Amandine Nachtergael · 2024 · Natural Products and Bioprospecting
91. Gut microbiome and NAFLD: impact and therapeutic potential
    Liwei Li, Fuqing Cai, Guo Chen, Zheng Liu, Jiamin Qin, Jiean Huang · 2024 · Frontiers in Microbiology
92. Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
    Pervej Alom Barbhuiya, Ameena Ahmed, Partha Pratim Dutta, Saikat Sen, Manash Pratim Pathak · 2025 · Current Nutrition Reports
93. Analysis of sex differences in dietary copper-fructose interaction-induced alterations of gut microbial activity in relation to hepatic steatosis
    Ming Song, Fang Yuan, Xiaohong Li, Xipeng Ma, Xinmin Yin, Eric Christian Rouchka, Xiang Zhang, Zhongbin Deng, Russell A. Prough, Craig James McClain · 2021 · Biology of Sex Differences
94. Indole supplementation ameliorates MCD-induced NASH in mice
    Bilian Zhu, Honggui Li, Bangchao Lu, Xinlei Guo, Chia‐Shan Wu, Fen Wang, Qingsheng Li, Linglin Xie, Shannon S. Glaser, Heather Francis et al. · 2022 · The Journal of Nutritional Biochemistry
95. Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis
    Yuan Zhang, Jason D. Kang, Derrick Zhao, Siddartha Ghosh, Yanyan Wang, Yunling Tai, Javier González‐Maeso, Masoumeh Sikaroodi, Patrick Martin Gillevet, H. Robert Lippman et al. · 2021 · Frontiers in Physiology
96. From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
    Gatzios, Alexandra, Rombaut, Matthias, Buyl, Karolien, De Kock, Joery, Rodrigues, Robim M., Rogiers, Vera, Vanhaecke, Tamara, Boeckmans, Joost · 2022 · Biomedicines
97. Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions
    Mohamad Jamalinia, Samira Saeian, Nima Nikkhoo, Amirhossein Nazerian, Kamran Bagheri Lankarani · 2025 · Metabolism and Target Organ Damage
98. Intravenous trimethylamine N-oxide infusion does not modify circulating markers of liver health, glucose tolerance, and milk production in early-lactation cows
    William A. Myers, Feiran Wang, Crystal Chang, A.N. Davis, Jorge Eduardo Rico, Brianna N. Tate, Tanya L. France, Linfeng Wang, J.W. McFadden · 2021 · Journal of Dairy Science
99. Pien Tze Huang Protects Against Non-Alcoholic Steatohepatitis by Modulating the Gut Microbiota and Metabolites in Mice
    Xianyi Zeng, Xiang Zhang, Hao Su, Hongyan Gou, Harry Cheuk-Hay Lau, Xiaoxu Hu, Ziheng Huang, Yan Li, Jun Qing Yu · 2022 · Engineering
100. Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice
     Kaichi Kasai, Naoya Igarashi, Yuki Tada, Koudai Kani, Shun Takano, Tsutomu Yanagibashi, Fumitake Usui‐Kawanishi, Shiho Fujisaka, Shiro Watanabe, Mayuko Ichimura‐Shimizu et al. · 2023 · International Journal of Molecular Sciences